Venus Remedies
-
Venus Remedies gets marketing approval for six chemotherapy drugs from the Philippines
Venus Remedies’ oncology wing has also secured marketing authorisation from Myanmar for another chemotherapy drug Venus Remedies has received marketing…
Read More » -
Venus Remedies launches antibiotic formulation Elores in Ecuador
The launch of Elores in Ecuador is expected to open the doors for the entry of the novel antibiotic adjuvant…
Read More » -
Venus Remedies extends its oncology portfolio in South Eastern Europe
The company is banking on the product registration from Serbia to pave the way for faster approvals for other countries…
Read More » -
Venus Remedies bags Saudi marketing approval for Enoxaparin in PFS
The company expects this marketing approval to enable it to rapidly expand its operations not only in Saudi Arabia, the…
Read More » -
Venus Remedies launches flagship R&D drug Elores in Oman
The company is targeting the $237-million antibiotic market in the GCC region, out of which 35 per cent accounts for…
Read More » -
Venus Remedies secures marketing authorisation for key cancer drugs from Philippines, Paraguay, Georgia and Moldova
The company has secured 506 marketing approvals for its oncology products across 76 countries Building upon its sizeable global presence in…
Read More » -
Venus Remedies bags approval to market Meropenem in Spain
The company has secured more than 120 marketing authorisations for meropenem throughout the world Venus Remedies has achieved yet another…
Read More » -
Venus Remedies bags Ukrainian GMP approval for Carbapenem, oncology parenteral facilities
With Ukraine extending GMP to all seven facilities of Venus Remedies in Baddi, the company is looking to expand its…
Read More » -
Venus Remedies secures Kenyan GMP Certification for its manufacturing facilities in Baddi
The approval paves the way for consolidating the company’s position in Kenya and other African markets as part of its…
Read More »